Clentiazem maleate

马来酸克仑硫卓

Report date: 2022/05/12 17:20:44
NME

Base Information

Drug NameClentiazem maleate
Drug Alias Name克仑硫卓LognaTA-3090
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockersImmunosuppressants
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsReperfusion InjuryHypertensionAtherosclerosis +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesMitsubishi Tanabe Pharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsReperfusion InjuryHypertensionAtherosclerosis +[4

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG